Sabini Elisabetta, Hazra Saugata, Ort Stephan, Konrad Manfred, Lavie Arnon
Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, 900 South Ashland Avenue, Chicago, IL 60607, USA.
J Mol Biol. 2008 May 2;378(3):607-21. doi: 10.1016/j.jmb.2008.02.061. Epub 2008 Mar 3.
Deoxycytidine kinase (dCK) is an essential nucleoside kinase critical for the production of nucleotide precursors for DNA synthesis. This enzyme catalyzes the initial conversion of the nucleosides deoxyadenosine (dA), deoxyguanosine (dG), and deoxycytidine (dC) into their monophosphate forms, with subsequent phosphorylation to the triphosphate forms performed by additional enzymes. Several nucleoside analog prodrugs are dependent on dCK for their pharmacological activation, and even nucleosides of the non-physiological L-chirality are phosphorylated by dCK. In addition to accepting dC and purine nucleosides (and their analogs) as phosphoryl acceptors, dCK can utilize either ATP or UTP as phosphoryl donors. To unravel the structural basis for substrate promiscuity of dCK at both the nucleoside acceptor and nucleotide donor sites, we solved the crystal structures of the enzyme as ternary complexes with the two enantiomeric forms of dA (D-dA, or L-dA), with either UDP or ADP bound to the donor site. The complexes with UDP revealed an open state of dCK in which the nucleoside, either D-dA or L-dA, is surprisingly bound in a manner not consistent with catalysis. In contrast, the complexes with ADP, with either D-dA or L-dA, adopted a closed and catalytically competent conformation. The differential states adopted by dCK in response to the nature of the nucleotide were also detected by tryptophan fluorescence experiments. Thus, we are in the unique position to observe differential effects at the acceptor site due to the nature of the nucleotide at the donor site, allowing us to rationalize the different kinetic properties observed with UTP to those with ATP.
脱氧胞苷激酶(dCK)是一种必需的核苷激酶,对DNA合成的核苷酸前体的产生至关重要。该酶催化脱氧腺苷(dA)、脱氧鸟苷(dG)和脱氧胞苷(dC)核苷最初转化为其单磷酸形式,随后由其他酶将其磷酸化为三磷酸形式。几种核苷类似物前药的药理激活依赖于dCK,甚至非生理性L-手性的核苷也能被dCK磷酸化。除了接受dC和嘌呤核苷(及其类似物)作为磷酰基受体外,dCK还可以利用ATP或UTP作为磷酰基供体。为了阐明dCK在核苷受体和核苷酸供体位点底物选择性的结构基础,我们解析了该酶与dA的两种对映体形式(D-dA或L-dA)形成的三元复合物的晶体结构,其中UDP或ADP结合在供体位点。与UDP形成的复合物显示dCK处于开放状态,其中核苷(D-dA或L-dA)以一种与催化不一致的方式结合。相比之下,与ADP形成的复合物(与D-dA或L-dA)采用了封闭且具有催化活性的构象。色氨酸荧光实验也检测到dCK因核苷酸性质而采用的不同状态。因此,由于供体位点核苷酸的性质,我们能够在受体位点观察到不同的效应,这使我们能够解释用UTP观察到的与用ATP不同动力学性质的原因。